Inactive Instrument

Calendar Synthetic Biologics Inc Nyse

Equities

US87164U1025

Chart calendar Synthetic Biologics Inc

767a5c1886aa1950a88974a8c60a.-z7BpdUxiFijo0QrkawMe7bL-nPaBjI4S_VkhsNY1K4.j3v19IZYxyjs0idC85VZGuyNjhWiaGRiJbZJt7EBtsCxTfiT7EHXKciVKw~84c5deb3dc3b145703b6e587e5d46c56

Upcoming events on Synthetic Biologics Inc

Today 09:30 pm American Society of Gene & Cell Therapy Meeting - Abstract No: 1760
02/06/2024 12:00 am American Society of Clinical Oncology Annual Meeting - Abstract Number: TPS4210
08/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
27/02/2025 Q4 2024 Earnings Release (Projected)
13/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Synthetic Biologics Inc

07/05/2024 04:30 pm Q1 2024 Earnings Release
25/03/2024 06:00 pm Q4 2023 Earnings Call
25/03/2024 05:30 pm Q4 2023 Earnings Release
20/03/2024 Benzinga Virtual Healthcare Summit
18/03/2024 07:30 pm BioEurope Spring Conference
18/01/2024 08:00 pm B. Riley Securities Oncology Conference - Fireside Chat
07/12/2023 01:40 am Emerging Growth Conference
13/11/2023 07:00 pm Q3 2023 Earnings Call
13/11/2023 06:30 pm Q3 2023 Earnings Release
07/11/2023 03:45 pm BIO Europe Conference
02/11/2023 09:30 am Emerging Growth Conference
23/10/2023 05:30 pm Investor Meeting - Key Opinion Leader
22/10/2023 03:30 pm European Society for Medical Oncology Congress
05/10/2023 07:10 pm Emerging Growth Conference
08/08/2023 06:00 pm Q2 2023 Earnings Call
08/08/2023 05:30 pm Q2 2023 Earnings Release
11/05/2023 06:00 pm Q1 2023 Earnings Call
11/05/2023 05:30 pm Q1 2023 Earnings Release
17/04/2023 03:30 pm European of Clinical Microbiology & Infectious Diseases Congress - Poster Number: (#P2280)
30/03/2023 06:00 pm Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-15,7
-16,3
3.92%
-10,2
-12,0
15.45%
-14,3
-12,4
-14.67%
-21,6
-19,7
-9.78%
-21,4
-21,9
2.13%

-28,6

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00
0,00
-
-10,1
-12,0
15.51%
-14,3
-12,4
-14.66%
-21,1
-19,6
-7.65%
-20,0
-21,4
6.78%

-28,6

Net income
Million USD
Released
Forecast
Spread
-16,1
-16,9
4.87%
-12,6
-12,9
2.3%
-23,2
-12,4
-86.35%
-19,7
-19,6
-0.39%
-18,3
-21,4
14.43%

-28,6

EPS
USD
Released
Forecast
Spread
-9,80
-10,3
4.85%
-6,60
-5,60
-17.86%
-1,90
-1,80
-5.56%
-1,31
-1,30
-0.77%
-1,14
-1,37
16.79%

-0,81

Announcement Date20/02/2004/03/2116/03/2230/03/2325/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread



-4,99
-4,80
-3.8%
-5,01
-6,42
21.96%
-7,33
-5,41
-35.55%
-5,18
-6,23
16.83%
-5,82
-5,47
-6.34%
-4,22
-6,40
34.11%
-6,22
-6,68
6.95%
-5,39
-6,57
17.95%

-6,86


-7,43


-7,72

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



-4,97
-5,11
2.68%
-4,85
-5,35
9.27%
-7,02
-5,52
-27.22%
-4,81
-6,23
22.78%
-5,44
-5,70
4.44%
-3,83
-6,40
40.17%
-5,91
-7,36
19.74%
-5,17
-6,57
21.41%

-6,86


-7,43


-7,72

Net income
Million USD
Released
Forecast
Spread



-4,97
-5,11
2.68%
-4,85
-5,35
9.27%
-5,59
-5,52
-1.38%
-4,48
-6,23
28.08%
-5,08
-5,70
10.74%
-3,30
-6,40
48.41%
-5,49
-7,36
25.5%
-5,17
-6,57
21.41%

-6,86


-7,43


-7,72

EPS
USD
Released
Forecast
Spread



-0,31
-0,40
22.5%
-0,33
-0,34
2.94%
-0,36
-0,35
-2.86%
-0,30
-0,39
23.08%
-0,34
-0,38
10.53%
-0,19
-0,42
54.76%
-0,33
-0,49
32.65%
-0,30
-0,19
-57.89%

-0,19


-0,21


-0,22

Announcement Date16/05/2211/08/2210/11/2230/03/2311/05/2308/08/2313/11/2325/03/2407/05/24---
  1. Stock Market
  2. Equities
  3. TOVX Stock
  4. Stock
  5. Calendar Synthetic Biologics Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW